350 related articles for article (PubMed ID: 29734357)
1. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
[TBL] [Abstract][Full Text] [Related]
2. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
3. Experimental study on the effect of cyclosporine A drug delivery system implanted in anterior chamber on high-risk corneal graft rejection.
Xie L; Shi W; Wang Z; Liu Z
Zhonghua Yan Ke Za Zhi; 2002 Jul; 38(7):422-5. PubMed ID: 12411004
[TBL] [Abstract][Full Text] [Related]
4. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
5. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
6. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
[TBL] [Abstract][Full Text] [Related]
7. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
Gao H; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
[TBL] [Abstract][Full Text] [Related]
8. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits.
Xin M; Wang T; Shi W; Wu X
J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
Shi W; Chen M; Xie L
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
[TBL] [Abstract][Full Text] [Related]
10. [Combined rapamycin eye drop in nanometer vector and poly (lactic acid) wafers of cyclosporine A effectively prevents high-risk corneal allograft rejection in rabbits].
Jiang W; Sun HM; Li XR; Yuan XB; Wang YQ; Zhang SX; Tian EJ; Yuan JQ
Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):550-5. PubMed ID: 19957680
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
[TBL] [Abstract][Full Text] [Related]
12. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
13. [Drug release and biocompatibility of cyclosporine A drug delivery system implanting into the anterior chamber].
Liu ZS; Xie LX; Shi WY; Li SW; Cai Q; Bei JZ; Wang SG
Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):108-12. PubMed ID: 15059564
[TBL] [Abstract][Full Text] [Related]
14. FK506 in a biodegradable glycolide-co-clatide-co-caprolactone polymer for prolongation of corneal allograft survival.
Shi W; Liu T; Xie L; Wang S
Curr Eye Res; 2005 Nov; 30(11):969-76. PubMed ID: 16282131
[TBL] [Abstract][Full Text] [Related]
15. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
Mahlberg K; Uusitalo RJ; Oksala O
Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
[TBL] [Abstract][Full Text] [Related]
16. Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice.
Jia L; Liu Y; Wang L; Zhu J; Huang Y
Cornea; 2014 Apr; 33(4):398-404. PubMed ID: 24573171
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer.
Xie L; Shi W; Wang Z; Bei J; Wang S
Cornea; 2001 Oct; 20(7):748-52. PubMed ID: 11588429
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes.
Theng JT; Ti SE; Zhou L; Lam KW; Chee SP; Tan D
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4895-9. PubMed ID: 14578414
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
[TBL] [Abstract][Full Text] [Related]
20. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Wang D; Huang Y
Mol Vis; 2012; 18():624-33. PubMed ID: 22509094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
